Deep Blue Medical Advances, Inc.
United States
- Durham, NC
- 22/04/2026
- Series A
- $5,600,000
Duke University spin-out, Deep Blue Medical Advances has developed a novel hernia mesh to address the unacceptably high rate of hernia occurrence and recurrence. Millions of hernia surgeries are done globally with billions of dollars in clinical cost.
Our surgeon-invented T-Line® Hernia Mesh with integral suture-like extensions is designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength. In addition, several additional products are in development, including an anchor clip for even faster, easier implantation; a biosynthetic version of the T-Line Hernia Mesh; and a coated composite version of the T-Line Mesh.
Deep Blue products enhance hernia surgery with a potentially significant impact on the $1.1B global hernia device market. Due to its simple yet revolutionary design, the T-Line® Hernia Mesh has the potential to reduce hernia occurrence and recurrence by preventing or reducing mesh fixation failure.
- Industry Medical Equipment Manufacturing
- Website https://www.deepbluemedical.com/
- LinkedIn https://www.linkedin.com/company/deep-blue-medical-advances-inc/
Related People
Bill PerryFounder
United States -
San Francisco, California
Driven executive with 29+ years experience in VC / private equity medical device start-ups and growth companies. Extensive domestic and international corporate leadership, including marketing, business development, sales, reimbursement, regulatory and operations experience in multiple medical specialties. Successful ventures encompassing significant corporate growth, multiple profitable exit strategies and a successful IPO, and key, central participation in fund-raising efforts.
Led several organizations including founding multiple entities and offices. Nine years living in Europe growing business internationally, 19 years based in the US/San Francisco Bay Area leading corporate functions and global/domestic activities.
Significant business development experience with more than 20 deals achieved including multi-million dollar JDA's, partnerships, CRADA's, licensing deals, and grants. Multiple significant corporate, direct-to-surgeon and direct-to-patient marketing initiatives, 19 product introductions, and development of new medical markets and applications.
Led product development efforts from concept to market launch with internal and outsourced development resources. Received several FDA 510(k)'s and CE Marks. Extensive experience with domestic and international medical device reimbursement.
Specialties: Start-up Leadership, Business Development, Marketing, Sales, Planning, Product Launch, Fundraising, Venture Capital, Medical Device, Reimbursement, Distribution, Advisory Boards
Deep Blue Medical Advances, Inc. | $5,600,000 | (Apr 22, 2026)
Exergy3 Limited | $13,523,900 | (Apr 22, 2026)
Ideally | $10,000,000 | (Apr 22, 2026)
Reliable Robotics Corporation | $160,000,000 | (Apr 22, 2026)
Humble Robotics | $24,000,000 | (Apr 22, 2026)
Qualitate | $7,000,000 | (Apr 22, 2026)
Syenta | $26,000,000 | (Apr 22, 2026)
ViewsML | $4,900,000 | (Apr 21, 2026)
Rivan Industries | $34,000,000 | (Apr 21, 2026)
Ultralight | $9,300,000 | (Apr 21, 2026)